“Patient response to revumenib has been good in other clinical trials,” explains Cuglievan. “But it’s also been short-lived when used...

Treatment with bicistronic CD19/CD22 CAR-T cell therapy has shown event-free survival improvements in children with relapsed or...

Early study results were so promising that the trial closed early, with findings published in the New England Journal of Medicine ...

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset of patients...

Children with a genetic risk of developing myelodysplastic syndromes (MDS) and other hematopoietic malignancies (HM), such as leukemias...

Childhood cancer survivors are more likely than the general population to develop subsequent leukemia, even 15 years or more after their...

A BC study found infant mice infected with a mild virus don’t develop leukemia. Could this work for humans? Read more:...

The Food and Drug Administration (FDA) expanded the approval of Jylamvo (methotrexate) to include children with acute lymphoblastic...

A new study has uncovered molecular markers in blood at birth that are linked to later development of acute lymphoblastic leukemia (ALL),...

Youngsters with T-cell acute lymphoblastic leukaemia (T-ALL) will be offered CAR T-cell therapy targeted at a specific protein, which has...